Cochrane Abstracts
L‐ornithine L‐aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"L‐ornithine L‐aspartate for Prevention and Treatment of Hepatic Encephalopathy in People With Cirrhosis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436628/all/Recombinant_growth_hormone_therapy_for_cystic_fibrosis_in_children_and_young_adults:_Cochrane_systematic_review. Accessed 19 April 2024.
L‐ornithine L‐aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436628/all/Recombinant_growth_hormone_therapy_for_cystic_fibrosis_in_children_and_young_adults:_Cochrane_systematic_review. Accessed April 19, 2024.
L‐ornithine L‐aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436628/all/Recombinant_growth_hormone_therapy_for_cystic_fibrosis_in_children_and_young_adults:_Cochrane_systematic_review
L‐ornithine L‐aspartate for Prevention and Treatment of Hepatic Encephalopathy in People With Cirrhosis [Internet]. In: Cochrane Abstracts. [cited 2024 April 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436628/all/Recombinant_growth_hormone_therapy_for_cystic_fibrosis_in_children_and_young_adults:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - L‐ornithine L‐aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis
ID - 436628
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436628/all/Recombinant_growth_hormone_therapy_for_cystic_fibrosis_in_children_and_young_adults:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
